Infliximab

Infliximab
Trade Name Remicade
Orphan Indication pediatric Crohn’s disease
USA Market Approval USA
USA Designation Date 2003-11-12 00:00:00
Sponsor Centocor, Inc.;200 Great Valley Parkway;Malvern, Pennsylvania, 19355